Front Page Demo Slide

HIPPA & HL7

1
2
3
4
LATEST NEWS:   Tests show no sign of Ebola in Swedish man - STOCKHOLM (Reuters) - Medical authorities in the Swedish capital said on Monday tests on a man brought into hospital over the weekend and suspected of potentially carrying Ebola showed no signs the deadly disease.
LATEST NEWS:   'Most exciting ever' Novartis drug points to huge sales - BARCELONA (Reuters) - Sales forecasts for Novartis's new heart failure drug are being ramped up by analysts after strikingly good clinical trial results for a medicine doctors expect to transform treatment of the deadly disease.
LATEST NEWS:   Cyberonics device improves heart function after Boston flop - BARCELONA (Reuters) - A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific.
LATEST NEWS:   Swedish hospital investigating possible case of Ebola: media - STOCKHOLM (Reuters) - A hospital in the Swedish capital is investigating a possible case of Ebola, Swedish media reported on Sunday.
LATEST NEWS:   Heart drug launch could be 'most exciting ever', says Novartis - BARCELONA (Reuters) - The expected launch of Novartis's new heart failure drug next year promises to be the company's most exciting ever and profit margins on the medicine will be good, its head of pharmaceuticals said on Sunday.
LATEST NEWS:   Study raises concerns over Servier, Amgen heart drug - BARCELONA (Reuters) - A major clinical study has raised concerns about a drug from private French company Servier that helps lower the heart rate and which was licensed to U.S. group Amgen last year.